Benefit of adjuvant chemoradiotherapy for gastric adenocarcinoma: A SEER population analysis

Gastrointestinal Cancer Research

Volumn 7, Issue 3-4, 2014, Pages 82-90

  Seyedin, Steven ^a   Wang, Pin Chieh ^a   Zhang, Quan ^a   Lee, Percy ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CONFIDENCE INTERVAL; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT INFORMATION; STOMACH ADENOCARCINOMA; TREATMENT OUTCOME;

EID: 84907522042     PISSN: 19347820     EISSN: 19347987     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Ferlay J, Shin HR, Bray F, et al: GLOBOCAN 2008 v2. 0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer, 2010. Available at: http://globocan. iarc. fr. Accessed 29 April 2013.
2. Fuchs CS, Mayer RJ: Gastric carcinoma. N Engl J Med 333: 32-41, 1995.
3. Hundahl SA, Phillips JL, Menck HR: The National Cancer Data Base Report on poor survival of U. S. gastric carcinoma patients treated with gastrectomy, 5th ed. American Joint Committee on Cancer staging, proximal disease, and the different disease hypothesis. Cancer 88: 921, 2000.
4. Macdonald JS, Smalley SR, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725-730, 2001.
5. Cunningham D, Alum WH, Stenning SP, et al: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer: results of MAGIC trial. N Engl J Med 355: 11-20, 2006.
6. Synder RA, Castaldo ET, Bailey CE, et al: Survival benefit of adjuvant radiation therapy for gastric cancer following gastrectomy and extended lymphadenectomy. Int J Surg Oncol 2012: 11-307670, 2012.
7. Park HS, Gross GP, Makarov DV, et al: Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy. Int J Radiat Oncol Biol Phys 83: 1365-1373, 2012.
8. Maruyama K, Gunven P, Okabayashi K, et al: Lymph node metastases of gastric cancer: general pattern in 1931 patients. Ann Surg 210: 596-602, 1989.
9. Sasako M, McCullouch P, Kinoshita T: New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 82346-351, 1995.
10. Hartgritik HH, van de Velde CH, Putter H, et al: Extended lymph node dissection for gastric cancer: who may benefit?-final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22: 2069-2077, 2004.